SUNNYVALE, Calif. , April 9, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY ) will report results for its third quarter ended March 31, 2015 on April 30, 2015 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m.
SUNNYVALE, Calif., March 5, 2015 -- Accuray Incorporated (Nasdaq: ARAY) and Christie InnoMed Inc. announced today that they have entered into sales agent agreements involving the CyberKnife® and TomoTherapy® System product portfolios in Canada. Under the terms of these agreements, Christie InnoMed
Patient with Brain Tumor Received Extremely Precise Treatment in Reduced Time SUNNYVALE, Calif. , March 2, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the first patient treatment has been completed using the CyberKnife ® M6™ System with the InCise™ Multileaf
SUNNYVALE, Calif. and LANCASTER, Pa. , Feb. 24, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) and Lancaster General Health announced today that the first commercially available InCise™ Multileaf Collimator (MLC) for the CyberKnife ® M6™ System has been received by Lancaster .
SUNNYVALE, Calif. , Feb. 17, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced that class A user licenses for Accuray products were awarded to 16 hospitals during February by the Chinese National Health and Family Planning Commission (NHFPC).
SUNNYVALE, Calif. , Feb. 9, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the Cowen 35th Annual Healthcare Conference in Boston on Monday, March 2, 2015 at 2:10pm ET . A live webcast of the presentation will be available
Advanced Radiation Therapy System Ideally Suited for Efficient, Effective Treatment of Range of Breast Cancer Cases SUNNYVALE, Calif. , Feb. 4, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the first TomoTherapy ® System in Latin America dedicated solely to the
SUNNYVALE, Calif. , Jan. 27, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2014 . Second Quarter Highlights Generates improved order volume with gross orders of $72.3 million Increases total
SUNNYVALE, Calif. , Jan. 12, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2014 on January 27, 2015 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
SUNNYVALE, Calif. , Dec. 16, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to present at the JP Morgan 33 rd Annual Healthcare Conference in San Francisco on Monday, January 12, 2015 at 4:00 p.m. PST / 7:00 p.m. EST .
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
